Synapse - Brett Carver

Results (144)

ERG-driven prostate cancer initiation is cell-context dependent and requires KMT2A and DOT1L

Journal Article

Feng, W.; Ladewig, E.; Lange, M.; Salsabeel, N.; Zhao, H.; Lee, Y. S.; Gopalan, A.; Luo, H.; Kang, W.; Fan, N.; more...
Nature Genetics (2025)

Fulltext@MSK | Save

Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ-cell tumors

Journal Article

Matulewicz, R. S.; Baky, F.; Liso, N.; Williams, B. M.; Porwal, S.; Assel, M.; Carver, B. S.; Bajorin, D. F.; Motzer, R. J.; Bosl, G. J.; more...
Annals of Oncology (2025)

Fulltext@MSK | Save

Uncoupling of Akt and mTOR signaling drives resistance to Akt inhibition in PTEN loss prostate cancers

Journal Article

Mao, N.; Lee, Y. S.; Salsabeel, N.; Zhang, Z.; Li, D.; Kaur, H.; Chen, X.; Chang, Q.; Mehta, S.; Barnes, J.; more...
Science Advances (2025)

Fulltext@MSK | Save

Pelvic lymph node dissection in prostate cancer: Update from a randomized clinical trial of limited versus extended dissection

Journal Article

Touijer, K. A.; Vertosick, E. A.; Sjoberg, D. D.; Liso, N.; Nalavenkata, S.; Melao, B.; Laudone, V. P.; Ehdaie, B.; Carver, B.; Eastham, J. A.; more...
European Urology (2025)

Fulltext@MSK | Save

Long-term outcomes of regressed or “burnt out” primary testicular germ cell tumors

Journal Article

Baky, F. J.; Liso, N.; Williams, B.; Reuter, V. E.; Tickoo, S. K.; Feldman, D. R.; Funt, S. A.; Carver, B. S.; Sheinfeld, J.; Matulewicz, R. S.
Urology (2024)

Fulltext@MSK | Save

Long-term clinical outcomes of patients with negative pathology (pN0) at primary retroperitoneal lymph node dissection

Journal Article

Baky, F.; Liso, N.; Williams, B.; Knezevic, A.; Funt, S. A.; Feldman, D. R.; Carver, B.; Sheinfeld, J.; Matulewicz, R. S.
Clinical Genitourinary Cancer (2024)

Fulltext@MSK | Save

Paclitaxel, ifosfamide, and cisplatin as initial salvage chemotherapy for germ cell tumors: Long-term follow-up and outcomes for favorable- and unfavorable-risk disease

Journal Article

Gleeson, J. P.; Knezevic, A.; Bromberg, M.; Patil, S.; Sheinfeld, J.; Carver, B. S.; Bains, M.; Jones, D. R.; Bajorin, D. F.; Bosl, G. J.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Role of tumor microenvironment derived NRG1 in androgen resistance: Implications for a novel prostate cancer treatment strategy

Meeting Abstract

Shinder, B.; Mao, N.; Salsabeel, N.; Zhang, Z.; Sawyers, C. L.; Carver, B. S.
Urologic Oncology: Seminars and Original Investigations (2024)

Fulltext@MSK | Save

Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC)